Author | John S. Linehan

John S. Linehan is an attorney in the Health Care and Life Sciences practice group of Epstein Becker Green. He can be reached at


Politics, Populism, and the Future of Prescription Drug Pricing Reform


Significant uncertainty surrounds the future of drug pricing reform, causing industry observers to take a closer look at the policy views of the president-elect, state and Congressional lawmakers, and the general public.

Drug Compounding: A Cause and Cure for High Drug Prices?

Pharmaceutical Executive


The practice’s emerging-if improbable-cost-saving potential.

Drug Compounding: Cause and Cure for High Drug Prices?


Just as insurers and regulators have sought to tamp down compounding costs and utilization, observers have begun to acknowledge that the practice may serve as an antidote to spiraling drug prices. John S. Linehan reports.